When bond markets are absorbing US$518b of new Treasury supply in a week and 1 year yields are sitting at 4.0% with real yields still below inflation, dividend growth stocks sit under a different kind of spotlight. Higher short term rates can change how investors weigh steady income, balance sheet strength and payout discipline. This article looks at three dividend growth stocks exposed to these bond market shifts, all drawn from a screener focused on consistent dividend increases and manageable payout ratios. It also explains how this tougher rate backdrop may influence decisions about holding them or, in some cases, avoiding them altogether.

Abbott Laboratories (ABT)

Overview: Abbott Laboratories is a global healthcare company that sells a wide range of products, including diagnostics, medical devices, branded generic medicines and nutrition products for children and adults.

Operations: Abbott generates most of its revenue from Medical Devices at US$22.0b, followed by Diagnostics at US$9.1b, Nutrition at US$8.3b, Established Pharmaceutical at US$5.7b and a small contribution from Other at US$16m.

Market Cap: US$154.2b

Income focused investors looking at Abbott Laboratories get a long dividend track record, exposure to high margin medical technologies like FreeStyle Libre and expanding cancer diagnostics, plus support from an aging population and wider healthcare access, but also clear trade offs. Earnings and margins recently came under pressure, debt is high and growth forecasts sit below the broader market, which matters more when 1 year Treasuries yield 4.0%. Yet the stock is trading well below one estimate of fair value, with analysts seeing potential upside if margins recover and recent acquisitions, such as Exact Sciences, and new products, like dual glucose ketone sensors and AI supported imaging, gain traction.

Abbott Laboratories’ pressured margins, elevated debt and below market growth forecasts sit awkwardly beside one estimate of upside potential. Before you move on, review the 4 key rewards and 2 important warning signs

Stryker (SYK)

Overview: Stryker is a global medical technology company that supplies surgeons and hospitals with orthopedic implants, surgical equipment, neurotechnology products and digital tools for operating rooms and virtual care, helping treat joint, trauma and brain conditions across about 61 countries.

Operations: Stryker generates most of its revenue from MedSurg and Neurotechnology at US$15.8b, with Orthopaedics contributing US$9.5b.

Market Cap: US$115.4b

Stryker attracts dividend growth investors because its core products tie directly to aging populations and higher procedure volumes. Recent launches such as the Pangea Plating System in Europe and the TPX HD small bone power tool indicate it is still pushing into high value surgical niches. Earnings growth has outpaced much of the medical equipment sector, Q1 2026 results showed higher sales and EPS, and analysts see room between the current share price and their consensus target, even as the stock carries a relatively high P/E and meaningful debt. With short term Treasury yields at 4.0% and cash suddenly paying more, the real question is whether Stryker’s cash generation, margin profile and dividend record justify staying the course when some insiders have recently been selling.

Stryker’s accelerating product rollouts and dividend record are only half the story, especially with a rich P/E and insider selling in the background. It is therefore worth reading the 4 key rewards and 2 important warning signs

Masco (MAS)

Overview: Masco is a home improvement products company that owns brands like Delta and Hansgrohe faucets and Behr paints, supplying fixtures, paint and hardware used in everyday repair, remodeling and wellness projects across North America, Europe and other markets.

Operations: Masco generates most of its revenue from Plumbing Products at US$5.1b, with Decorative Architectural Products contributing about US$2.6b.

Market Cap: US$14.4b

Masco stands out in dividend growth investing because it ties a portfolio of well known plumbing and paint brands to themes like aging housing stock, longer homeowner tenure and demand for smart, sustainable upgrades. These are supported by solid cash generation and share buybacks. At the same time, high debt and a heavy tilt to North American repair and remodel mean slower revenue growth forecasts and added funding risk just as short term yields move to 4.0% and above, giving investors more choices for income. With Q1 2026 results showing higher sales and EPS, a fresh US$1.0b credit facility for bolt on deals and a steady dividend, the tension between Masco’s quality profile and its leverage story is exactly what income focused investors need to weigh carefully.

Masco’s steady cash generation and home repair exposure could be masking a much sharper trade off between leverage and dividend growth than headline numbers suggest, so walk through the 5 key rewards and 1 important warning sign.

The three dividend growth stocks covered here are just a starting point, with the full screener surfacing 38 more companies in the Dividend Growth Stocks screener that carry similarly detailed income, balance sheet and payout stories. Use Simply Wall St to apply filters around dividend growth histories, payout ratios, balance sheet strength and specific catalysts so you can identify and analyze the dividend narratives that best match your highest conviction ideas.

Take Control of Your Investment Journey

If Masco or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Still Seeking Alternatives Worth Your Curiosity

Fresh stock ideas can move quickly, and attractive entry points often appear just before momentum becomes a widely followed story. Consider acting early rather than reacting late.

• Watch for early momentum in companies linked to electrification and infrastructure by scanning the curated 34 power grid technology and infrastructure stocks before they shift from under the radar to more fully reflected in market prices.
• Monitor potential opportunities in resource producers by filtering the hand picked 33 elite gold producer stocks while sentiment remains mixed and prices may not yet reflect evolving expectations.
• Explore developments in industrial automation by reviewing the carefully selected 31 robotics and automation stocks before adoption trends move from steady progress to more widely followed coverage.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.